Literature DB >> 3920853

The effect of propranolol on circulating thyroid hormone measurements in thyrotoxic and euthyroid subjects.

J A Franklyn, M R Wilkins, R Wilkinson, D B Ramsden, M C Sheppard.   

Abstract

Circulating concentrations of total and free thyroid hormones and thyroid hormone binding proteins were measured in thyrotoxic and euthyroid subjects treated with propranolol. In the thyrotoxic group, total triiodothyronine (T3) concentration fell after propranolol therapy, suggesting an effect of the drug on the peripheral conversion of thyroxine (T4) to T3. In euthyroid subjects, a rise in circulating concentrations of free T4 and reverse T3 (rT3) was observed, while only a small decrease in free T3 was evident. Thyroxine binding globulin (TBG) concentration fell during propranolol treatment while thyroxine binding prealbumin (TBPA) concentration rose. The changes observed in the euthyroid state are consistent with inhibition of peripheral deiodination of T4 and rT3; an additional effect of propranolol on binding protein metabolism was evident.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3920853     DOI: 10.1530/acta.0.1080351

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  4 in total

1.  [Early changes in thyroid hormones following radioiodine therapy of hyperthyroidism with reference to etiology and accompanying medication].

Authors:  T Kreisig; W Abenhardt; K Mann; C M Kirsch; E Moser
Journal:  Klin Wochenschr       Date:  1989-04-03

Review 2.  The effects of drugs on tests of thyroid function.

Authors:  P H Davies; J A Franklyn
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 3.  Drug-induced thyroid disorders.

Authors:  N J Gittoes; J A Franklyn
Journal:  Drug Saf       Date:  1995-07       Impact factor: 5.606

4.  Effects of Antihypertensive Drugs on Thyroid Function in Type 2 Diabetes Patients With Euthyroidism.

Authors:  Lijuan Yang; Xiuqin Sun; Yi Zhao; Hong Tao
Journal:  Front Pharmacol       Date:  2022-03-07       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.